Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies

This publication has 44 references indexed in Scilit:

• Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years
  Clinical Immunology, 2009
• Measurement of CD8⁺ T Cell Responses in Human Type 1 Diabetes
  Annals of the New York Academy of Sciences, 2008
• Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children
  Clinical and Experimental Immunology, 2008
• The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
  Proceedings of the National Academy of Sciences, 2007
• Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients
  Proceedings of the National Academy of Sciences, 2007
• HLA Class I Epitope Discovery in Type 1 Diabetes
  Annals of the New York Academy of Sciences, 2006
• HLA class II tetramers: Tools for direct analysis of antigen-specific CD4+ T cells
  Arthritis & Rheumatism, 2002
• Cytotoxic T Cells to an Epitope in the Islet Autoantigen IA-2 Are Not Disease-Specific
  Clinical Immunology, 2001
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
  Nature, 1999
• Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.
  The Journal of Experimental Medicine, 1995